HUTCHMED (China) (HMDCF) Enterprise Value (2014 - 2025)
HUTCHMED (China) (HMDCF) reported Enterprise Value of -$1.5 billion for Q4 2025, down 1286.61% year-over-year from $123.9 million in Q4 2024, and down 8.76% quarter-over-quarter from -$1.4 billion in Q2 2025.
HUTCHMED (China) (HMDCF) Enterprise Value (2014 - 2025) Analysis & Trends
HUTCHMED (China) (HMDCF) has 12 years of Enterprise Value data on file, last reported at -$1.5 billion in Q4 2025.
- Enterprise Value for Q4 2025 came in at -$1.5 billion, down 1286.61% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.5 billion (down 1286.61% YoY), and the FY2025 annual result was -$174.1 million, up 38.28% from the prior year.
- Enterprise Value retreated to -$1.5 billion in Q4 2025 per HMDCF's latest filing, from -$1.4 billion in the prior quarter.
- Over five years, Enterprise Value peaked at $1.6 billion in Q4 2023 and troughed at -$1.5 billion in Q4 2025.
- A 5-year average of -$374.8 million and a median of -$249.4 million in 2021 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value soared 2227.31% in 2023, then tumbled 1286.61% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$123.1 million in 2021, then surged by 37.24% to -$77.3 million in 2022, then soared by 2227.31% to $1.6 billion in 2023, then sank by 106.45% to -$106.0 million in 2024, then plunged by 1286.61% to -$1.5 billion in 2025.
- Business Quant data shows HMDCF's Enterprise Value at -$1.5 billion in Q4 2025, -$1.4 billion in Q2 2025, and -$106.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -498.58 Mn |
| 10 | HUTCHMED (China) | - | - | - | -1.47 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.47 Bn |
| Jun 30, 2025 | -1.35 Bn |
| Dec 31, 2024 | -106.02 Mn |
| Jun 30, 2024 | -101.12 Mn |
| Dec 31, 2023 | 1.64 Bn |
| Jun 30, 2023 | -944.16 Mn |
| Dec 31, 2022 | -77.28 Mn |
| Jun 30, 2022 | -774.08 Mn |
| Dec 31, 2021 | -123.12 Mn |
| Jun 30, 2021 | -569.74 Mn |
| Mar 31, 2021 | -249.45 Mn |
| Dec 31, 2020 | -320.70 Mn |
| Jun 30, 2020 | -327.30 Mn |
| Mar 31, 2020 | -121.16 Mn |
| Dec 31, 2019 | -182.05 Mn |
| Sep 30, 2019 | -166.26 Mn |
| Jun 30, 2019 | -212.14 Mn |
| Mar 31, 2019 | -241.62 Mn |
| Dec 31, 2018 | -276.92 Mn |
| Sep 30, 2018 | -85.27 Mn |